Renal cancer vaccine (immatics)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameRenal cancer vaccine (immatics)
Drug Alias Name肾癌疫苗 - immaticsIMA-901
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionCD4-positive T-lymphocytes stimulantsCD8-positive T-Lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandRomania +[11
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesImmatics Biotechnologies Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCarcinoma, Renal Cell

Other Information

ATC CodeN/A
Related LinksN/A